Cochrane Abstracts
Amyloid‐beta‐targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Amyloid‐beta‐targeting Monoclonal Antibodies for People With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440905/all/Amyloid‐beta‐targeting_monoclonal_antibodies_for_people_with_mild_cognitive_impairment_or_mild_dementia_due_to_Alzheimer’s_disease.
Amyloid‐beta‐targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440905/all/Amyloid‐beta‐targeting_monoclonal_antibodies_for_people_with_mild_cognitive_impairment_or_mild_dementia_due_to_Alzheimer’s_disease. Accessed August 10, 2026.
Amyloid‐beta‐targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440905/all/Amyloid‐beta‐targeting_monoclonal_antibodies_for_people_with_mild_cognitive_impairment_or_mild_dementia_due_to_Alzheimer’s_disease
Amyloid‐beta‐targeting Monoclonal Antibodies for People With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 August 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440905/all/Amyloid‐beta‐targeting_monoclonal_antibodies_for_people_with_mild_cognitive_impairment_or_mild_dementia_due_to_Alzheimer’s_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amyloid‐beta‐targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease
ID - 440905
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440905/all/Amyloid‐beta‐targeting_monoclonal_antibodies_for_people_with_mild_cognitive_impairment_or_mild_dementia_due_to_Alzheimer’s_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
